Purpose: Urinary tract infection (UTI) is the second-most-common type of infection in China. This study aimed to determine the long-term trends in the incidence of UTI in Mainland China between 1990 and 2019. Materials and Methods: Data were extracted from the Global Burden of Disease Study 2019 and were analyzed with the age–period–cohort framework. Results: The net drift in the incidence of UTI was – 0.37% (95% CI: – 0.40%, – 0.35%) in males and – 0.25% (95% CI: – 0.29%, – 0.20%) in females. For males, the local drift was lower than 0 (P< 0.05) among those younger than 90 years. For females, the local drift was lower than 0 (P< 0.05) among those younger than 60 years and higher than 0 (P< 0.05) in those aged 65– 79 years. In the same birth cohort, the incidence of UTI was higher in females than in males in all age groups (P< 0.05). The period relative risk (RR) showed a decreasing pattern after 2005 in both sexes. The cohort RR showed a downward trend of the birth cohort after 1905 for males and 1960 for females. Conclusion: The incidence has increased significantly among older females over the past 30 years. It is necessary to develop a comprehensive intervention plan for reproductive health services covering females and males of all ages.
7 January 2025 in Journal of the American Heart Association
Background: The optimal definition and risk stratification approach to identify high‐risk patients with prediabetes and stable coronary heart disease has not been well studied to date. The objective of the current study is to compare the prognostic value of different definitions of prediabetes, and to explore the role of “very‐high‐risk” (VHR) criteria according to the 2018 American Heart Association/American College of Cardiology cholesterol guideline in the risk stratification of patients with prediabetes and stable coronary heart disease. Methods and Results: This prospective large‐cohort study enrolled a total of 7930 patients with stable coronary heart disease. Prediabetes was defined according to various guidelines and further classified on the basis of the VHR criteria according to the 2018 American Heart Association/American College of Cardiology guideline. The primary end point was major adverse cardiovascular events (MACEs), which was defined as the composite end point of cardiac death, nonfatal acute myocardial infarction, and stroke. During a median of 3 years’ follow‐up, a total of 256 MACEs occurred. Prediabetes defined according to the World Health Organization/International Expert Committee criteria was associated with significant increased MACE risk compared with normoglycemia (adjusted hazard ratio [HR], 1.484 [95% CI, 1.139–1.935]; P =0.0035). The VHR group was associated with increased MACE risk compared with the non‐VHR group (adjusted HR, 1.783 [95% CI, 1.344–2.366], P <0.0001). The VHR criteria played an important role in risk stratification, and prediabetes combined with VHR criteria was associated with higher MACE risk regardless of the prediabetes definition. Conclusions: Our findings suggested the potential use of the World Health Organization/International Expert Committee definition and VHR criteria in risk stratification of patients with prediabetes and stable coronary heart disease.
7 July 2026 in Journal of the American Heart Association
Background: Complex percutaneous coronary intervention is associated with higher risk of long‐term worse cardiovascular outcomes than noncomplex procedures. Stress hyperglycemia ratio (SHR), a biomarker to reflect relative hyperglycemia, has been shown to predict risk of cardiovascular events in patients with coronary artery disease. However, whether SHR‐related cardiovascular risk could be seen in patients who underwent complex percutaneous coronary intervention who are at high risk of cardiovascular events remained undetermined. Methods: This prospective cohort study consecutively recruited 12 220 patients who underwent complex percutaneous coronary intervention from January 2017 to December 2018 at Fuwai Hospital. Patients were categorized according to baseline SHR tertiles (tertile 1: ≤ 0.765; T2: 0.765–0.879 and T3: > 0.879). The primary end point was cardiovascular events including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke. Results: During a median 3‐year follow‐up, 389 cardiovascular events (3.6% of the 10 772 patients who completed follow‐up) were recorded. Overall, per 1‐unit increase in SHR values was associated with 1.62‐fold (95% CI, 1.10–2.38) risk of cardiovascular events after adjusting for confounding factors. Upon stratification by glycemic status, in the fully adjust model, elevated SHR was associated with increased risk of cardiovascular events in diabetic patients (T3 vs. T1; hazard ratio [HR], 1.67 [95% CI, 1.20–2.32]). Conclusions: We found that elevated SHR levels were associated with increased risk of cardiovascular events at long‐term follow‐up in patients who underwent complex percutaneous coronary intervention, especially in those with diabetes, suggesting that it could help in risk stratification and prognosis in this population.